Insider Trading & Ownership - VINCENT RICHARD G

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for VINCENT RICHARD G
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-04-13
Purchase
2023-04-14
06:00 am
Oncternal Therapeutics Inc.ONCTVINCENT RICHARD G
Chief Financial Officer
30,000$0.2987$8,961163,219
(Indirect
Direct)
View
2022-03-24
Purchase
2022-03-28
4:00 pm
Oncternal Therapeutics Inc.ONCTVINCENT RICHARD G
Chief Financial Officer
5,000$1.4421$7,21094,522
(Indirect
Direct)
View
2022-01-27
Purchase
2022-01-31
4:00 pm
Oncternal Therapeutics Inc.ONCTVINCENT RICHARD G
Chief Financial Officer
12,500$1.73$21,62589,522
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-02-14
Option Award
2024-02-15
6:00 pm
N/A
2034-02-14
Oncternal Therapeutics Inc.ONCTVINCENT RICHARD G
Chief Financial Officer
14,200$014,200
(Direct)
View
2024-01-03
Tax Withholding
2024-01-05
4:00 pm
N/A
N/A
Oncternal Therapeutics Inc.ONCTVINCENT RICHARD G
Chief Financial Officer
8,868$0.4961147,282
(Direct)
View
2023-10-02
Option Award
2023-10-04
4:59 pm
N/A
2029-09-12
Oncternal Therapeutics Inc.ONCTVINCENT RICHARD G
Chief Financial Officer
738,467$0738,467
(Direct)
View
2023-10-02
Disposition
2023-10-04
4:59 pm
N/A
2029-09-12
Oncternal Therapeutics Inc.ONCTVINCENT RICHARD G
Chief Financial Officer
738,449$0738,467
(Direct)
View
2023-07-03
Tax Withholding
2023-07-05
6:58 pm
N/A
N/A
Oncternal Therapeutics Inc.ONCTVINCENT RICHARD G
Chief Financial Officer
7,069$0.36156,150
(Direct)
View
2023-02-21
Option Award
2023-02-23
8:00 pm
N/A
2033-02-21
Oncternal Therapeutics Inc.ONCTVINCENT RICHARD G
Chief Financial Officer
210,000$0210,000
(Direct)
View
2023-01-03
Tax Withholding
2023-01-05
6:00 pm
N/A
N/A
Oncternal Therapeutics Inc.ONCTVINCENT RICHARD G
Chief Financial Officer
4,428$1.02133,219
(Direct)
View
2022-07-28
Option Award
2022-08-01
6:19 pm
N/A
2032-07-28
Oncternal Therapeutics Inc.ONCTVINCENT RICHARD G
Chief Financial Officer
71,875$0166,397
(Direct)
View
2022-01-20
Option Award
2022-01-24
4:00 pm
N/A
2032-01-20
Oncternal Therapeutics Inc.ONCTVINCENT RICHARD G
Chief Financial Officer
109,579$0109,579
(Direct)
View
2022-01-03
Option Award
2022-01-05
7:00 pm
N/A
N/A
Oncternal Therapeutics Inc.ONCTVINCENT RICHARD G
Chief Financial Officer
29,867$077,022
(Direct)
View
2021-02-11
Option Award
2021-02-16
6:00 pm
N/A
2031-02-11
Oncternal Therapeutics Inc.ONCTVINCENT RICHARD G
Chief Financial Officer
280,000$0280,000
(Direct)
View
2020-03-17
Option Award(A)
2020-07-31
9:05 pm
N/A
2030-03-17
Oncternal Therapeutics Inc.ONCTVINCENT RICHARD G
Chief Financial Officer
35,120$035,120
(Direct)
View
2019-09-12
Option Award(A)
2020-07-31
9:05 pm
N/A
2029-09-12
Oncternal Therapeutics Inc.ONCTVINCENT RICHARD G
Chief Financial Officer
75,000$075,000
(Direct)
View
2020-03-17
Option Award
2020-03-18
6:49 pm
N/A
2030-03-17
Oncternal Therapeutics Inc.ONCTVINCENT RICHARD G
Chief Financial Officer
35,120$035,120
(Direct)
View
2019-09-12
Option Award
2019-09-16
5:38 pm
N/A
2029-09-12
Oncternal Therapeutics Inc.ONCTVINCENT RICHARD G
Chief Financial Officer
75,000$075,000
(Direct)
View
2019-06-07
Option Award
2019-06-11
6:34 pm
N/A
2028-11-14
GTX INCONCTVINCENT RICHARD G
Chief Financial Officer
122,654$0116,294
(Direct)
View
(A) Indicate amendment filing.